Clinical Trial Detail

NCT ID NCT02387996
Title A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

urethra transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma

Therapies

Nivolumab

Age Groups: adult

No variant requirements are available.